Panel Discussion: Discussing the Future Indications of GLP-1-Based Therapeutics – Promises & Challenges

Time: 2:30 pm
day: Conference Day One


  • Advancing the reach of GLP-1-based treatments into other therapeutic areas, particularly Alzheimer’s and Parkinson’s disease
  • Exploring the scientific validity of the latest treatment frontiers with GLP-1s to understand the potential in these areas
  • Considering the commercial possibilities of these new therapeutic area markets to grasp the scope of opportunity